EW Edwards Lifesciences
Edwards Lifesciences earnings company data as of 7:06 PM ET 10/30
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 4 Nov | EPS | 0.73 | — | — |
| Rev | $1.68B | — | — |
Insider trades
Open-market buys and sales by EW's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $13.2M sold by 7 insiders outside a trading plan
- $14.5M sold by 4 insiders under 10b5-1 plans
-
Daniel J. Lippis Cvp, TavrPlanned sale$53K 619 shares at $85.65 1.5% of stakeTraded Oct 8 Filed Oct 8
-
Daniel J. Lippis Cvp, TavrPlanned sale$54K 619 shares at $87.51 1.5% of stakeTraded Sep 11 Filed Sep 11
-
Andrew M. Dahl SVP, Corporate ControllerSale$50K 544 shares at $91.06 3.5% of stakeTraded Aug 31 Filed Aug 31
-
Annette Bruls Cvp, EmeaclaSale$238K 2,644 shares at $89.98 13% of stakeTraded Aug 28 Filed Aug 28
-
Daveen Chopra CVP, TMTT, Surgical & IHFMSale$2.9M 31,800 shares at $91.02 42% of stakeTraded Aug 26 Filed Aug 26
-
Wayne Markowitz Cvp, JapacSale$113K 1,240 shares at $91.47 5.8% of stakeTraded Aug 26 Filed Aug 26
-
Daniel J. Lippis Cvp, TavrPlanned sale$57K 619 shares at $92.03 1.5% of stakeTraded Aug 11 Filed Aug 11
-
Wayne Markowitz Cvp, JapacSale$13K 146 shares at $86.03 0.7% of stakeTraded Jul 30 Filed Jul 30
-
Wayne Markowitz Cvp, JapacSale$819K 9,628 shares at $85.06 31% of stakeTraded Jul 28 Filed Jul 28
-
Bernard J Zovighian CEOSale$245K 2,921 shares at $83.93 25% of stakeTraded Jul 27 Filed Jul 27
-
Daniel J. Lippis Cvp, TavrPlanned sale$57K 619 shares at $91.70 1.5% of stakeTraded Jul 10 Filed Jul 10
-
Daniel J. Lippis Cvp, TavrPlanned sale$57K 619 shares at $91.40 1.5% of stakeTraded Jun 30 Filed Jun 30
-
Bernard J Zovighian CEOPlanned sale$46K 523 shares at $87.92 4.3% of stakeTraded Jun 17 Filed Jun 17
-
Andrew M. Dahl SVP, Corporate ControllerSale$49K 568 shares at $86.08 3.6% of stakeTraded May 29 Filed May 29
-
Donald E Bobo Jr. CVP,Strategy/Corp DevelopmentSale$2M 23,145 shares at $86.42 19% of stakeTraded May 27 Filed May 27
Also filed in the last 12 months, not counted as buying or selling: 36 share withholdings for taxes, 30 option exercises, 22 stock grants, and 15 gifts.
SEC filings
Recent issuer filings from EDGAR, 3 shown.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.